Retraction note to: Molecular Cancer
https://doi.org/10.1186/s12943-015-0315-3
The Editor-in-Chief has retracted this article [1] because Figure 6b overlaps with Figure 8 of [2] and Figure 4a overlaps with Figure 2b of [3]. An investigation by Zhengzhou University has confirmed that these figures overlap. The data reported in this article are therefore unreliable. Guoqiang Zhao agrees with this retraction. Wenqiao Zang, Yuanyuan Wang, Tao Wang, Yuwen Du, Xiaonan Chen and Min Li have not responded to any correspondence about this retraction.
References
Zang W, Wang Y, Wang T, Du Y, Chen X, Li M, et al. miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Mol Cancer. 2015;14:37. https://doi.org/10.1186/s12943-015-0315-3.
Wang T, Zang W, Li M, et al. Dig Dis Sci. 2013;58:706. https://doi.org/10.1007/s10620-012-2395-x.
Wang T, Xuan X, Li M, et al. Diagn Pathol. 2013;8:179. https://doi.org/10.1186/1746-1596-8-179 Retracted article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Zang, W., Wang, Y., Wang, T. et al. Retraction Note: miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Mol Cancer 18, 118 (2019). https://doi.org/10.1186/s12943-019-1042-y
Published:
DOI: https://doi.org/10.1186/s12943-019-1042-y